The treatment of Alzheimer's disease

This publication has 237 references indexed in Scilit:

• Secretory processing of the Alzheimer amyloid βA4 protein precursor is increased by protein phosphorylation
  Biochemical and Biophysical Research Communications, 1992
• Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells
  Neuroscience Letters, 1991
• Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4-Tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's Disease: Preliminary Findings
  The Journal of Clinical Pharmacology, 1990
• Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family
  Neuroscience Letters, 1989
• Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer Agent
  The Journal of Clinical Pharmacology, 1989
• Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal rats
  Developmental Brain Research, 1988
• Morphological response of axotomized septal neurons to nerve growth factor
  Journal of Comparative Neurology, 1988
• Recovery of cortical acetylcholine output after ganglioside treatment in rats with lesion of the nucleus basalis
  Neuroscience Letters, 1987
• Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type
  Neuroscience Letters, 1984
• Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type
  Life Sciences, 1980